Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma ; volume:12 ; number:1 ; day:28 ; month:8 ; year:2015 ; pages:1 ; date:12.2015
Retrovirology ; 12, Heft 1 (28.8.2015), 1, 12.2015
- Urheber
-
Yonekura, Kentro
Tokunaga, Masahito
Kawakami, Nobuyo
Takeda, Koichiro
Kanzaki, Tamotsu
Takatsuka, Yoshifusa
Nakano, Nobuaki
Kubota, Ayumu
Takeuchi, Syogo
Utsunomiya, Atae
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-12-S1-P66
- URN
-
urn:nbn:de:101:1-2020100521025769797059
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yonekura, Kentro
- Tokunaga, Masahito
- Kawakami, Nobuyo
- Takeda, Koichiro
- Kanzaki, Tamotsu
- Takatsuka, Yoshifusa
- Nakano, Nobuaki
- Kubota, Ayumu
- Takeuchi, Syogo
- Utsunomiya, Atae
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antitumor activity of monoclonal anti-CEA antibody-saporin immunotoxin in colon cancer cells
Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Establishment of anti-mesothelioma monoclonal antibodies
A biomimetic assay platform for the interrogation of antigen-dependent anti-tumor T-cell function
TH9 cells in anti-tumor immunity
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia
PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity
Antitumor activity of monoclonal anti-CEA antibody-saporin immunotoxin in colon cancer cells
Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Establishment of anti-mesothelioma monoclonal antibodies
A biomimetic assay platform for the interrogation of antigen-dependent anti-tumor T-cell function
TH9 cells in anti-tumor immunity
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia
PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity
Antitumor activity of monoclonal anti-CEA antibody-saporin immunotoxin in colon cancer cells
Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report
Establishment of anti-mesothelioma monoclonal antibodies
A biomimetic assay platform for the interrogation of antigen-dependent anti-tumor T-cell function
TH9 cells in anti-tumor immunity
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia